Specifically, we found EPS8, DSG2, RHOD, ITGB6, ANKRD37, SELENBP1, FOXA3, and ALDH1A1 could be potential biomarkers to accurately predict the prognosis of pancreatic cancer patients. Here, FOXA3 is linked to familial pancreatic carcinoma.